These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24944390)

  • 21. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma.
    Poinoosawmy D; Indar A; Bunce C; Garway-Heath DF; Hitchings RA
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):721-6. PubMed ID: 12271368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%.
    García-Feijoo J; Martínez-de-la-Casa JM; Castillo A; Méndez C; Fernández-Vidal A; García-Sánchez J
    Curr Med Res Opin; 2006 Sep; 22(9):1689-97. PubMed ID: 16968572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
    Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of a large scale change in regimen from latanoprost to travoprost in glaucoma patients at the Manhattan Veterans Administration Hospital.
    Farris EP
    Clin Ophthalmol; 2008 Jun; 2(2):303-12. PubMed ID: 19668721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulsatile ocular blood flow: the effect of the Valsalva manoeuvre in open angle and normal tension glaucoma: a case report and prospective study.
    Khan JC; Hughes EH; Tom BD; Diamond JP
    Br J Ophthalmol; 2002 Oct; 86(10):1089-92. PubMed ID: 12234884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
    Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucoma.
    Mishra D; Sinha BP; Kumar MS
    Korean J Ophthalmol; 2014 Oct; 28(5):399-407. PubMed ID: 25276082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.
    Centofanti M; Oddone F; Gandolfi S; Hommer A; Boehm A; Tanga L; Sangermani C; Sportelli V; Haustein M; Manni G; Rossetti L
    Am J Ophthalmol; 2010 Oct; 150(4):575-80. PubMed ID: 20688314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow.
    Georgopoulos GT; Diestelhorst M; Fisher R; Ruokonen P; Krieglstein GK
    Acta Ophthalmol Scand; 2002 Feb; 80(1):54-8. PubMed ID: 11906305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of intraocular pressure reducing effects of three prostaglandin eyedrops in open-angle glaucoma].
    Huang HL; Sun XH; Xiao M
    Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):109-13. PubMed ID: 21426839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the long-term visual field consequences of average daily intraocular pressure and variance : a clinical trial comparing timolol, latanoprost and travoprost.
    Nordmann JP; Lepen C; Lilliu H; Berdeaux G
    Clin Drug Investig; 2003; 23(7):431-8. PubMed ID: 17535054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulsatile ocular blood flow in primary open-angle glaucoma and ocular hypertension.
    Kerr J; Nelson P; O'Brien C
    Am J Ophthalmol; 2003 Dec; 136(6):1106-13. PubMed ID: 14644222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized crossover study of latanoprost and travoprost in eyes with open-angle glaucoma.
    Sawada A; Yamamoto T; Takatsuka N
    Graefes Arch Clin Exp Ophthalmol; 2012 Jan; 250(1):123-9. PubMed ID: 21858678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular hypotensive efficacy of travoprost in patients unsuccessfully treated with latanoprost.
    Kaback M; Geanon J; Katz G; Ripkin D; Przydryga J;
    Curr Med Res Opin; 2004 Sep; 20(9):1341-5. PubMed ID: 15383181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A challenge to primary open-angle glaucoma including normal-pressure. Clinical problems and their scientific solution].
    Sugiyama K
    Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):233-67; discussion 268. PubMed ID: 22568103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraocular pressure control with latanoprost/timolol and travoprost/timolol fixed combinations : a retrospective, multicentre, cross-sectional study.
    Denis P; Lafuma A; Jeanbat V; Laurendeau C; Berdeaux G
    Clin Drug Investig; 2008; 28(12):767-76. PubMed ID: 18991470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension.
    Goldberg I; Cunha-Vaz J; Jakobsen JE; Nordmann JP; Trost E; Sullivan EK;
    J Glaucoma; 2001 Oct; 10(5):414-22. PubMed ID: 11711841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.
    Parmaksiz S; Yuksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y
    Eur J Ophthalmol; 2006; 16(1):73-80. PubMed ID: 28221484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
    Ota T; Murata H; Sugimoto E; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.